Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: J Hepatol. 2008 Mar 7;48(6):903–913. doi: 10.1016/j.jhep.2008.01.030

Table 1.

Chronic, Recovered and Normal Control Subjects

Chornic N=61 Normal (HCV Ab−/HCV RNA−) N=11 Recovered (HCV Ab+/HCV RNA−) N=15 p(Recovered vs. Chronic)
Male/Female 61/0 5/6 13/2 p=0.037
White/Black/Other 15/43/3 7/3/1 8/7/0 p=0.08

Median Range Median Range Median Range

Age (years) 52 35–69 44 24–46 51 42–64 p=0.030
HCA RNA (IU/ml) 773500 8,620–18,900,000 p<0.0001
ALT (U/ML) 47 13–326 22 13–43 22 12–39 p<0.0001
Albumin (g/dl) 4.1 3.4–5.3 4.2 3.8–4.7 4.4 3.9–4.9 p=0.052
Total Bilirubin (mg/dl) 0.8 0.2–1.9 0.4 0.2–1.4 0.7 0.2–1.1 p=0.11
INR 1.0 0.9–1.12 1.0 1.0–1.2 1.0 0.9–1.2 p=0.47
Platelet (× 1000/ml) 235 96–456 243 203–346 244 154–305 p=0.54